0102030405
CAS No 863127-77-9 DASATINIB MONOHYDRATE Pharmaceutical Intermediates
02
Product detail
Product detail
Dasatinib monohydrate is a potent tyrosine kinase inhibitor that plays a vital role in the treatment of certain types of cancer. Its chemical formula isC22H28ClN7O3S, and its molecular weight is506.02 g/mol. The product is a White to Off-White Solid with high solubility in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, and moderate solubility in water.
The presence of the monohydrate improves the stability and solubility of the compound, making it suitable for a variety of drug formulations. The melting point of dasatinib monohydrate is approximately 200-205°C, which helps it maintain stability under various storage conditions. The unique structure of the compound enables it to effectively inhibit a variety of tyrosine kinases, which are crucial in the signaling pathways of cancer cell proliferation.
02
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
1. Enhanced stability: Compared to the anhydrous form, the monohydrate of dasatinib has higher stability, reducing the risk of degradation and ensuring a longer shelf life.
2. High Bioavailability: Dasatinib monohydrate is designed to achieve high bioavailability, allowing for efficient absorption and utilization by the body, which is critical for therapeutic efficacy.
3. Targeted effect: As a selective inhibitor of multiple tyrosine kinases, dasatinib monohydrate can effectively target cancer cells while minimizing the impact on normal cells, thereby leading to better patient treatment outcomes.
4. Multiple formulation options: The product can be easily incorporated into a variety of drug formulations, including tablets, capsules, and injections, providing flexibility to manufacturers.
5. Regulatory Compliance: Our manufacturing processes adhere to Good Manufacturing Practice (GMP) and other regulatory standards to ensure that dasatinib monohydrate is safe and effective in pharmaceutical applications.
Dasatinib monohydrate is primarily used in the pharmaceutical industry to treat hematological malignancies, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Its ability to inhibit specific tyrosine kinases involved in cancer cell proliferation makes it a key ingredient in targeted cancer therapy.
In addition to its use in oncology, dasatinib monohydrate is also being explored for use in other therapeutic areas, including autoimmune diseases and other malignancies. Ongoing research and development in this area highlights the versatility of this compound and its potential for broader application.
As a factory integrating production and trading, we focus on quality at every stage of operation. Our state-of-the-art production facilities are equipped with advanced technology and adhere to strict quality control measures. We purchase raw materials from reputable suppliers and conduct rigorous testing to ensure that Dasatinib Monohydrate meets the highest standards of purity and efficacy.
Our dedicated team is committed to providing exceptional customer service, ensuring our customers receive the support they need throughout the purchasing process. We understand the importance of timely delivery and work hard to meet our customers' needs efficiently.
In summary, Dasatinib monohydrate is a high-quality pharmaceutical product that offers numerous advantages for cancer treatment and other therapeutic applications. With our commitment to quality and customer satisfaction, we are your trusted partner in the pharmaceutical industry. Choose Dasatinib monohydrate for reliable performance and superior results.